Invention Grant
- Patent Title: Anti-IL-17 antibodies
- Patent Title (中): 抗IL-17抗体
-
Application No.: US12908892Application Date: 2010-10-21
-
Publication No.: US08110191B2Publication Date: 2012-02-07
- Inventor: Barrett Allan , Chi-Kin Chow , Ling Liu , Jirong Lu , Jonathan Wendell Tetreault , Ying Tang
- Applicant: Barrett Allan , Chi-Kin Chow , Ling Liu , Jirong Lu , Jonathan Wendell Tetreault , Ying Tang
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Gregory A. Cox
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24
Abstract:
Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
Public/Granted literature
- US20110027290A1 ANTI-IL-17 ANTIBODIES Public/Granted day:2011-02-03
Information query
